# DataMeds AI, Inc.: filings

MEDS · Nasdaq · CIK 2030763 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/meds.md) · [Financials](/companies/meds/financials.md) · [Filings](/companies/meds/filings.md) · [Insiders](/companies/meds/insiders.md)

## Reports and events: 88 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 59, 3 17, CORRESP 14, 4 13, S-1/A 11, UPLOAD 11, 10-Q 5, 8-K/A 5, EFFECT 4, NT 10-Q 4, PRE 14C 4, S-1 4, 10-K 2, 424B3 2, 424B4 2, 4/A 2, DEF 14C 2, DRS 2, PRE 14A 2, 10-K/A 1, 8-A12B 1, CERT 1, DEF 14A 1, DRS/A 1, DRSLTR 1, FWP 1, PRER14A 1, PRER14C 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 17:00 ET | [8-K](/filings/0001493152-26-048573.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048573 |
| 2026-10-20 | 09:24 ET | [8-K](/filings/0001493152-26-047711.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047711 |
| 2026-10-16 | 17:15 ET | [8-K](/filings/0001493152-26-047451.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity | 0001493152-26-047451 |
| 2026-10-13 | 17:27 ET | [8-K](/filings/0001493152-26-046887.md) | 8.01 Other events | 0001493152-26-046887 |
| 2026-10-09 | 17:20 ET | [S-1/A](/filings/0001493152-26-046608.md) | Registration statement, amended | 0001493152-26-046608 |
| 2026-09-17 | 17:23 ET | [8-K](/filings/0001493152-26-043169.md) | 8.01 Other events | 0001493152-26-043169 |
| 2026-09-16 | 17:11 ET | [8-K](/filings/0001493152-26-042951.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042951 |
| 2026-08-18 | 07:43 ET | [8-K](/filings/0001493152-26-038891.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038891 |
| 2026-08-17 | 06:05 ET | [10-Q](/filings/0001493152-26-038581.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038581 |
| 2026-08-14 | 16:46 ET | [8-K](/filings/0001493152-26-038475.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038475 |
| 2026-08-07 | 17:23 ET | [S-1](/filings/0001493152-26-036665.md) | Registration statement | 0001493152-26-036665 |
| 2026-08-04 | 16:30 ET | [8-K](/filings/0001493152-26-036005.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-036005 |
| 2026-07-29 | 19:14 ET | [8-K](/filings/0001493152-26-035058.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-035058 |
| 2026-07-21 | 16:15 ET | [8-K](/filings/0001493152-26-034086.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-034086 |
| 2026-06-12 | 16:32 ET | [8-K](/filings/0001493152-26-028464.md) | 3.01 Delisting notice; 8.01 Other events | 0001493152-26-028464 |
| 2026-06-03 | 16:15 ET | [8-K/A](/filings/0001493152-26-027063.md) | 9.01 Financial statements and exhibits | 0001493152-26-027063 |
| 2026-06-02 | 16:15 ET | [8-K/A](/filings/0001493152-26-026879.md) | 9.01 Financial statements and exhibits | 0001493152-26-026879 |
| 2026-05-29 | 17:30 ET | [8-K](/filings/0001493152-26-026452.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026452 |
| 2026-05-21 | 16:10 ET | [8-K](/filings/0001493152-26-024823.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024823 |
| 2026-05-21 | 06:51 ET | [8-K](/filings/0001493152-26-024723.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-024723 |
| 2026-05-19 | 17:11 ET | [8-K](/filings/0001493152-26-024454.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-024454 |
| 2026-05-19 | 16:05 ET | [10-Q](/filings/0001493152-26-024413.md) | Quarterly report, period 2026-03-31 | 0001493152-26-024413 |
| 2026-05-19 | 06:11 ET | [8-K](/filings/0001493152-26-024324.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-024324 |
| 2026-05-18 | 07:20 ET | [8-K](/filings/0001493152-26-024058.md) | 8.01 Other events | 0001493152-26-024058 |
| 2026-05-07 | 16:13 ET | [8-K](/filings/0001493152-26-021718.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-021718 |
| 2026-05-04 | 16:05 ET | [8-K/A](/filings/0001493152-26-021102.md) | 1.01 Entry into a material agreement | 0001493152-26-021102 |
| 2026-05-04 | 16:05 ET | [DEF 14A](/filings/0001493152-26-021106.md) | Proxy statement, period 2026-05-04 | 0001493152-26-021106 |
| 2026-04-24 | 17:03 ET | [10-K/A](/filings/0001493152-26-018958.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-018958 |
| 2026-04-21 | 16:46 ET | [8-K/A](/filings/0001493152-26-018326.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018326 |
| 2026-04-17 | 16:45 ET | [8-K](/filings/0001493152-26-017895.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-017895 |
| 2026-04-09 | 16:35 ET | [8-K](/filings/0001493152-26-015898.md) | 1.01 Entry into a material agreement; 8.01 Other events | 0001493152-26-015898 |
| 2026-04-07 | 16:42 ET | [8-K](/filings/0001493152-26-015548.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-015548 |
| 2026-03-20 | 17:27 ET | [10-K](/filings/0001493152-26-012004.md) | Annual report, period 2025-12-31 | 0001493152-26-012004 |
| 2026-03-11 | 17:15 ET | [8-K](/filings/0001493152-26-009702.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009702 |
| 2026-03-09 | 17:00 ET | [8-K](/filings/0001493152-26-009384.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009384 |
| 2026-02-13 | 17:27 ET | [8-K](/filings/0001493152-26-006815.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006815 |
| 2026-02-09 | 17:25 ET | [8-K](/filings/0001493152-26-005819.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005819 |
| 2026-02-05 | 17:21 ET | [8-K](/filings/0001493152-26-005387.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-005387 |
| 2026-01-20 | 06:04 ET | [8-K](/filings/0001493152-26-002690.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-002690 |
| 2026-01-08 | 17:25 ET | [8-K](/filings/0001493152-26-001001.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-001001 |
| 2025-12-19 | 16:30 ET | [8-K](/filings/0001493152-25-028571.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-028571 |
| 2025-12-16 | 20:33 ET | [8-K](/filings/0001493152-25-027830.md) | 3.01 Delisting notice | 0001493152-25-027830 |
| 2025-12-08 | 16:30 ET | [8-K](/filings/0001493152-25-026652.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-026652 |
| 2025-12-05 | 16:05 ET | [8-K](/filings/0001493152-25-026358.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-026358 |
| 2025-11-26 | 16:30 ET | [8-K](/filings/0001493152-25-025169.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025169 |
| 2025-11-26 | 09:23 ET | [8-K/A](/filings/0001493152-25-025072.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025072 |
| 2025-11-25 | 17:00 ET | [8-K](/filings/0001493152-25-024999.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-024999 |
| 2025-11-20 | 16:35 ET | [8-K](/filings/0001493152-25-024471.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-024471 |
| 2025-11-19 | 17:23 ET | [10-Q](/filings/0001493152-25-024328.md) | Quarterly report, period 2025-09-30 | 0001493152-25-024328 |
| 2025-11-17 | 17:20 ET | [8-K](/filings/0001493152-25-023918.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-25-023918 |

Page 1 of 2. [Older](/companies/meds/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:01 ET. No prices; not investment advice.